# Early Dehiscence Markers in Ovarian Cancer Surgery

> **NCT03131492** · — · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 92 (actual)

## Conditions studied

- Ovarian Neoplasms Malignant
- Anastomotic Leak

## Interventions

- **DIAGNOSTIC_TEST:** Blood test

## Key facts

- **NCT ID:** NCT03131492
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2022-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03131492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03131492, "Early Dehiscence Markers in Ovarian Cancer Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03131492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*